Yan Xie
- Oncology top 5%
- Pathology and Forensic Medicine top 5%
- Molecular Biology
- Immunology top 10%
- Rehabilitation top 2%
- Co-authors
- Jun ZhuYuqin SongZee UptonWen ZhengXiaopei WangNingjing LinDavid I. LeavesleyLingyan Ping
- Topics
- Lymphoma Diagnosis and Treatment (50 papers)Viral-associated cancers and disorders (22 papers)CNS Lymphoma Diagnosis and Treatment (15 papers)
- Journals
- SHILAP Revista de lepidopterologíaBloodBiomaterials
In The Last Decade
Yan Xie
68 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Oncology 520
- Pathology and Forensic Medicine 441
- Molecular Biology 259
- Immunology 231
- Rehabilitation 190
Countries citing papers authored by Yan Xie
This map shows the geographic impact of Yan Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Xie more than expected).
Fields of papers citing papers by Yan Xie
This network shows the impact of papers produced by Yan Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Xie. The network helps show where Yan Xie may publish in the future.
Co-authorship network of co-authors of Yan Xie
This figure shows the co-authorship network connecting the top 25 collaborators of Yan Xie. A scholar is included among the top collaborators of Yan Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Xie. Yan Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 50 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | Anticancer activity of 1, 25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway | 1 |
| 7 | 8 | |
| 8 | 11 | |
| 9 | 28 | |
| 10 | 6 | |
| 11 | 11 | |
| 12 | 23 | |
| 13 | 7 | |
| 14 | 29 | |
| 15 | 18 | |
| 16 | Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy | 5 |
| 17 | 85 | |
| 18 | Clinical observation on rituximab combined with chemotherapy in the treatment of diffused large B cell lymphoma. | 0 |
| 19 | 69 | |
| 20 | 98 |
About Yan Xie
Yan Xie is a scholar working on Pathology and Forensic Medicine, Rehabilitation and Oncology, having authored 78 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (50 papers), Viral-associated cancers and disorders (22 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). The work is most often cited by research in Rehabilitation (190 citations), Pathology and Forensic Medicine (441 citations) and Oncology (520 citations). Yan Xie has collaborated with scholars based in China, Ethiopia and Australia. Frequent co-authors include Jun Zhu, Yuqin Song, Zee Upton, Wen Zheng, Xiaopei Wang, Ningjing Lin, David I. Leavesley, Lingyan Ping, Weiping Liu and Zhitao Ying. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.